/
© 2026 RiffOn. All rights reserved.

Get your free personalized podcast brief

We scan new podcasts and send you the top 5 insights daily.

  1. The BioHub - by Avetix
  2. Episode 222 - Steve Tregay - Managing General Partner Mission Biocapital
Episode 222 - Steve Tregay - Managing General Partner Mission Biocapital

Episode 222 - Steve Tregay - Managing General Partner Mission Biocapital

The BioHub - by Avetix · Sep 8, 2026

Mission Bio Capital's Steve Tregay on building great biotech teams, navigating funding, and Big Pharma's critical role in the innovation ecosystem.

Early-Stage Biotech CEOs Should Plan for 'Tours of Duty,' Not Lifelong Roles

The ideal CEO for a biotech startup changes as it matures. The person excelling at early-stage discovery may not be the best for taking a company public. Founders should see their role as a finite 'tour of duty,' focusing on the company's immediate needs rather than assuming permanent leadership.

Episode 222 - Steve Tregay - Managing General Partner Mission Biocapital thumbnail

Episode 222 - Steve Tregay - Managing General Partner Mission Biocapital

The BioHub - by Avetix·2 months ago

Risk-Averse VCs Counterintuitively Fund Bigger, Tranched Rounds to De-Risk Biotech Startups

In cautious markets, biotech VCs aren't writing smaller checks; they are committing to larger rounds structured in tranches. This guarantees future capital if milestones are met, reducing financing risk. Founders must now present a comprehensive path to clinical proof of concept, not just a development candidate, to secure these large commitments.

Episode 222 - Steve Tregay - Managing General Partner Mission Biocapital thumbnail

Episode 222 - Steve Tregay - Managing General Partner Mission Biocapital

The BioHub - by Avetix·2 months ago

Mission Bio Capital Inverts VC Power Dynamics by Becoming a Partner Before an Investor

By offering lab space and operational support first, Mission Bio Capital establishes relationships with founders by solving their immediate problems. This transforms the traditional power dynamic from a 'begging for money' pitch to a partnership, where capital becomes a natural extension of an already collaborative relationship.

Episode 222 - Steve Tregay - Managing General Partner Mission Biocapital thumbnail

Episode 222 - Steve Tregay - Managing General Partner Mission Biocapital

The BioHub - by Avetix·2 months ago

Great Biotech Boards Fill a Founder's Skill Gaps, Not Just Echo Their Vision

Effective boards are not just collections of supporters. Founders should strategically recruit members with specific expertise they lack—such as legal, finance, or late-stage R&D. This creates a complementary team to navigate diverse challenges, provided everyone is fundamentally aligned with the company's ultimate vision.

Episode 222 - Steve Tregay - Managing General Partner Mission Biocapital thumbnail

Episode 222 - Steve Tregay - Managing General Partner Mission Biocapital

The BioHub - by Avetix·2 months ago

Biotech Startups Must Operate Locally But Compete Globally From Day One

While company building is inherently local, the competition for capital and pharma partnerships is global. Startups, even those outside major hubs like Kendall Square, need immediate exposure to global standards to succeed. The goal isn't to be the best idea in your city, but the best idea in the world.

Episode 222 - Steve Tregay - Managing General Partner Mission Biocapital thumbnail

Episode 222 - Steve Tregay - Managing General Partner Mission Biocapital

The BioHub - by Avetix·2 months ago

A Biotech CEO's Most Critical Skill Is an Irrational Belief in Success

Biotech is fraught with failure. A CEO's most important function is to embody an 'irrational belief' they will succeed against all odds. This conviction is a strategic tool for recruiting great people and motivating the team to overcome countless hurdles by focusing on the single reason it will work.

Episode 222 - Steve Tregay - Managing General Partner Mission Biocapital thumbnail

Episode 222 - Steve Tregay - Managing General Partner Mission Biocapital

The BioHub - by Avetix·2 months ago